Mobile Application-Based Interventions for People with Heart Failure: A Systematic Review and Meta-Analysis

被引:1
|
作者
Ni, Yun-Xia [1 ]
Liu, Xue-Hui [1 ]
He, Li [1 ]
Wen, Ya [1 ]
You, Gui-Ying [1 ]
机构
[1] Sichuan Univ, West China Hosp, West China Sch Nursing, Dept Cardiol, Chengdu, Peoples R China
关键词
SELF-CARE; MANAGEMENT; SMARTPHONE; EFFICACY; QUALITY;
D O I
10.1155/2024/6859795
中图分类号
C93 [管理学];
学科分类号
12 ; 1201 ; 1202 ; 120202 ;
摘要
Aim. To examine the effectiveness of mobile health application-based interventions on mortality, hospitalization rate, self-care, and quality of life in people with heart failure. Background. Mobile health application-based interventions are reported to potentially help people with heart failure improve health-related clinical outcomes. However, evidence on the effects of mobile health application-based interventions on mortality, hospitalization, self-care, and quality of life remains inconclusive and limited. Methods. A systematic literature search was conducted in six databases (MEDLINE, CINAHL Plus with Full Text, PsycINFO, Web of Science, EMBASE, and CENTRAL) to identify relevant studies from inception to 21 October 2023. Two authors independently extracted the data and assessed the risk of bias using the Cochrane risk-of-bias tool. The meta-analysis was conducted in Review Manager (version 5.4) and the statistical software R 4.3.3. Sensitivity analysis and subgroup analysis were also performed. The certainty of the evidence was evaluated by the GRADE approach. Results. Twenty-four studies involving 2886 participants were identified in this review. The pooled analysis showed that mobile health application-based interventions had statistically significant beneficial effects on reducing heart failure-related hospitalization (RR = 0.72, 95% CI 0.57 to 0.91, p=0.01) and improving quality of life (SMD = 0.46, 95% CI 0.09 to 0.83, p=0.02), but had no statistically significant effects on all-cause mortality (RR = 0.90, 95% CI 0.66 to 1.25, p=0.47), cardiovascular mortality (RR = 0.87, 95% CI 0.59 to 1.26, p=0.24), all-cause hospitalization (RR = 0.74, 95% CI 0.39 to 1.42, p=0.29), or self-care (MD = -2.42, 95% CI -15.07 to 10.24, p=0.64). Subgroup analyses indicated that intervention duration and monitoring frequency may influence the effects of mobile health application-based interventions on quality of life. Conclusions. Mobile health application-based interventions were effective at reducing heart failure-related hospitalization and improving quality of life in people with heart failure. More well-designed randomized controlled trials are needed to strengthen the evidence. Implications for Nursing Management. Mobile health application-based interventions may have benefits for improving heart failure-related hospitalization and quality of life. More rigorous studies are warranted to confirm the effects of mobile health application-based interventions for people with heart failure.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] A systematic review and meta-analysis of frailty in patients with heart failure
    Chen, Xia
    Meng, Xiangying
    JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2024,
  • [42] Palliative care in heart failure: a systematic review and meta-analysis
    Liao, C. T. Chia-Te
    Kuo, F. H.
    Liu, S. L.
    Lee, M. C.
    Lai, H. Y.
    Kung, S. C.
    Tai, W. C.
    Weng, T. C.
    Ko, P. L.
    Toh, H. S.
    Chen, Z. C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 165 - 165
  • [43] Ivabradine for the treatment of heart failure: A systematic review and meta-analysis
    Aljohani, Hadir
    Alkofide, Hadeel
    Aljohani, Hanin
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 498 - 498
  • [44] Heart failure in Nigeria: protocol for a systematic review and meta-analysis
    Ogah, Okechukwu S.
    Kushimo, Oyewole A.
    Adebiyi, Adewole
    Onyema, Chuka T.
    Uchenna, Onubogu C.
    Adebayo, Bosede E.
    Agaja, Oyinkansola T.
    Orimolade, Olanike A.
    Durodola, Amina
    Makinde, Isa A.
    Akinyemi, Rufus O.
    Adedeji, Waheed A.
    Adekanmi, Ademola J.
    Akinyemi, Joshua O.
    Adedokun, Babatunde
    AFRICAN HEALTH SCIENCES, 2023, 23 (02) : 530 - 536
  • [45] TOLVAPTAN FOR HEART FAILURE, SYSTEMATIC REVIEW AND META-ANALYSIS OF TRIALS
    Alskaf, Ebraham
    Tridente, Ascanio
    Al-Mohammad, Abdallah
    HEART, 2016, 102 : A1 - A1
  • [46] Home Telemonitoring In Heart Failure: A Systematic Review And Meta-Analysis
    Pekmezaris, Renee
    Tortez, Leanne
    Williams, Myia
    Patel, Vidhi
    Makaryus, Amgad
    Zeltser, Roman
    Sinvani, Liron
    Wolf-Klein, Gisele
    Lester, Janice
    Sison, Cristina
    Lesser, Martin
    Kozikowski, Andrzej
    HEALTH AFFAIRS, 2018, 37 (12) : 1983 - 1989
  • [47] Vericiguat treatment of heart failure: A systematic review and meta-analysis
    Yang, Heng
    Luo, Chao
    Lan, Wan-Qi
    Tang, Yan-Hua
    WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (35) : 8330 - 8342
  • [48] The prevalence of frailty in heart failure: A systematic review and meta-analysis
    Denfeld, Quin E.
    Winters-Stone, Kerri
    Mudd, James O.
    Gelow, Jill M.
    Kurdi, Sawsan
    Lee, Christopher S.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 236 : 283 - 289
  • [49] Tolvaptan for Heart Failure, Systematic Review and Meta-Analysis of Trials
    Alskaf, E.
    Tridente, A.
    Al-Mohammad, A.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2016, 68 (03) : 196 - 203
  • [50] Cognitive Impairment and Heart Failure: Systematic Review and Meta-Analysis
    Cannon, Jane A.
    Moffitt, Peter
    Perez-Moreno, Ana Cristina
    Walters, Matthew R.
    Broomfield, Mall M.
    Mcmurray, John J. V.
    Quinn, Terence J.
    JOURNAL OF CARDIAC FAILURE, 2017, 23 (06) : 464 - 475